Explore

Trendline Trendline
Gaelic and Athlone Labs Complete Phase 1 Integration to Strengthen Beta-Lactam Antibiotics Production

Gaelic and Athlone Labs Complete Phase 1 Integration to Strengthen Beta-Lactam Antibiotics Production

Gaelic and Athlone Labs Complete Phase 1 Integration to Strengthen Beta-Lactam Antibiotics Production
Rapid Read Rapid Read
FDA's New Approach to Peptides Raises Concerns Over Drug Development Incentives

FDA's New Approach to Peptides Raises Concerns Over Drug Development Incentives

The U.S. Food and Drug Administration (FDA) is taking steps to make peptides more accessible by removing regulatory barriers that prevent their production in specialized pharmacies. This move is part of a broader trend where peptides, short chains of amino acids, are gaining popularity as potential treatments for various conditions. Despite their potential, many peptides remain unapproved for human use, leading to concerns about the lack of scientific evidence supporting their efficacy. Former FDA official Peter Lurie has expressed worries that this regulatory shift could deter pharmaceutical companies from investing in the development of new drugs, as it might reduce the incentive to bring effective drugs to market through the traditional approval process.
Rapid Read Rapid Read
Critical Path Institute to Host Global Impact Conference on Drug Development in Washington, D.C.

Critical Path Institute to Host Global Impact Conference on Drug Development in Washington, D.C.

The Critical Path Institute (C-Path) is set to host its 2026 Global Impact Conference (CGIC) in Washington, D.C., from September 15-16, with a special session on September 17. The conference will focus on establishing a new paradigm for generating evidence of drug efficacy and safety. Keynote speakers include Michael Davis, M.D., Ph.D., acting director of the FDA's Center for Drug Evaluation and Research, and Janet Woodcock, M.D., former principal deputy commissioner of the FDA. The event will bring together leaders from regulatory agencies, the pharmaceutical industry, academia, and advocacy groups to address challenges in drug development. The agenda includes discussions on artificial intelligence, real-world data, digital health technologies, and biomarker development.
AP News AP News
Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden

South Africa is rolling out lenacapavir, a twice-yearly injectable drug for HIV prevention that the president calls a turning point in a country with the world’s highest burden of HIV
Rapid Read Rapid Read
NASA Satellites Reveal Complex Changes in Global Air Pollution Impacting Climate

NASA Satellites Reveal Complex Changes in Global Air Pollution Impacting Climate

NASA's ongoing research has highlighted the significant impact of air pollution on global health and climate. According to recent findings, outdoor air pollution is responsible for approximately 4 million premature deaths annually, with an additional 3-4 million deaths attributed to indoor air pollution. This accounts for about one in nine deaths worldwide. NASA satellites have been instrumental in tracking changes in pollutants such as ozone, nitrogen dioxide, and particulate matter, which are closely linked to fossil fuel usage, emission control effectiveness, wildfire distribution, and economic fluctuations. The increase in climate gases like methane and carbon dioxide due to human activities is also having a profound effect on Earth's climate. NASA's atmospheric models utilize these observations to better understand the impact of trace gas emissions on air pollution and climate change, aiding policymakers in designing effective mitigation strategies.
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Ingredient Options

FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Ingredient Options

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol for use in American sunscreens, marking the first new active ingredient approval since the 1990s. Bemotrizinol is a chemical compound that provides broad-spectrum protection against UVA and UVB rays. It has been used in Europe and Asia for decades and is known for its stability and low absorption into the body. The approval process was expedited under the CARES Act, which aims to streamline the approval of over-the-counter drugs. Health and Human Services Secretary Robert F. Kennedy Jr. stated that this move will enhance competition and consumer confidence in sunscreen products.
AP News AP News
FDA OKs first new sunscreen ingredient in more than 25 years

FDA OKs first new sunscreen ingredient in more than 25 years

Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years
Trendline Trendline
PCMA Introduces Policy Platform to Address Drug Affordability Challenges

PCMA Introduces Policy Platform to Address Drug Affordability Challenges

PCMA Introduces Policy Platform to Address Drug Affordability Challenges
Rapid Read Rapid Read
Bundibugyo Virus Outbreak in Congo and Uganda Escalates, Prompting International Response

Bundibugyo Virus Outbreak in Congo and Uganda Escalates, Prompting International Response

The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo is rapidly evolving, with a significant increase in confirmed cases and deaths. As of June 6, 2026, there are 515 confirmed cases and 91 deaths in the Democratic Republic of the Congo, while Uganda has reported 19 confirmed cases and two deaths. The outbreak has spread across borders, with evidence of both imported infections and secondary transmission among contacts and healthcare workers in Uganda. In response, national authorities, in collaboration with the World Health Organization (WHO) and partners, have launched a comprehensive response plan. The Africa Centres for Disease Control and Prevention (Africa CDC) and WHO have initiated a joint Ebola continental preparedness and response plan, seeking $518 million to support African countries in preparing for, detecting, and responding to the outbreak.
Rapid Read Rapid Read
FDA Adds Bemotrizinol to Approved Sunscreen Filters, Boosting UV Defense

FDA Adds Bemotrizinol to Approved Sunscreen Filters, Boosting UV Defense

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new sunscreen filter, the first addition in over two decades. This chemical UV filter, already used in Europe, offers broader protection against UV light, including long-wave UVA rays, which are associated with skin cancer. Dermatologists in the U.S. are optimistic about the ingredient's potential to enhance sunscreen efficacy, as it is photostable and less likely to irritate sensitive skin. The approval aligns with efforts to modernize U.S. sunscreen regulations and improve consumer access to advanced sun protection.
Trendline Trendline
Chinese Biotech Firms Gain Prominence at ASCO 2026 in Oncology Innovations

Chinese Biotech Firms Gain Prominence at ASCO 2026 in Oncology Innovations

Chinese Biotech Firms Gain Prominence at ASCO 2026 in Oncology Innovations